Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0166-6851(02)00282-7PMID 12615314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid Parasites*

  2003cited by this paper
• Protein prenyltransferases

  2003cited by this paper
• TcRho1, a Farnesylated Rho Family Homologue from Trypanosoma cruzi

  2001cited by this paper
• Current status of clinical trials of farnesyltransferase inhibitors

  2001cited by this paper
• Drosophila embryos lacking N-myristoyltransferase have multiple developmental defects.

  2001cited by this paper
• Fatty acid synthesis in African trypanosomes: a solution to the myristate mystery.

  2001cited by this paper
• Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.

  2001cited by this paper
• CAP5.5, a life-cycle-regulated, cytoskeleton-associated protein is a member of a novel family of calpain-related proteins in Trypanosoma brucei.

  2001cited by this paper
• The biology and enzymology of protein N-myristoylation.

  2001influential reference
• The δ Subunit of Type 6 Phosphodiesterase Reduces Light-induced cGMP Hydrolysis in Rod Outer Segments*

  2001cited by this paper
• Characterization of N-myristoyltransferase from Plasmodium falciparum.

  2000cited by this paper
• Molecular Cloning, Genomic Organization, and Biochemical Characterization of Myristoyl-CoA:ProteinN-Myristoyltransferase from Arabidopsis thaliana *

  2000cited by this paper
• Cloning, Heterologous Expression, and Distinct Substrate Specificity of Protein Farnesyltransferase from Trypanosoma brucei *

  2000cited by this paper
• Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral Leishmaniasis1

  2000cited by this paper
• Binding of the delta subunit to rod phosphodiesterase catalytic subunits requires methylated, prenylated C-termini of the catalytic subunits.

  2000cited by this paper
• Acylation-dependent Protein Export inLeishmania *

  2000cited by this paper
• A Novel Phosphatidylinositol-Phospholipase C of Trypanosoma cruzi That Is Lipid Modified and Activated during Trypomastigote to Amastigote Differentiation*

  2000cited by this paper
• Myristic acid analogs are inhibitors of Junin virus replication.

  1999cited by this paper
• Flagellar protein localization mediated by a calcium–myristoyl/palmitoyl switch mechanism

  1999cited by this paper
• The structure of myristoyl-CoA:protein N-myristoyltransferase.

  1999cited by this paper
• Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins.

  1999cited by this paper
• GTPases in protozoan parasites: tools for cell biology and chemotherapy.

  1999cited by this paper
• Crystal structure of the anti-fungal target N-myristoyl transferase

  1998cited by this paper
• Protein prenyl transferase activities of Plasmodium falciparum.

  1998cited by this paper
• A Second Mammalian N-Myristoyltransferase*

  1998cited by this paper
• Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.

  1998cited by this paper
• Genetic and Biochemical Studies Establish That the Fungicidal Effect of a Fully Depeptidized Inhibitor of Cryptococcus neoformans Myristoyl-CoA:ProteinN-Myristoyltransferase (Nmt) Is Nmt-dependent*

  1998cited by this paper
• The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth.

  1998cited by this paper
• Prenylation of proteins in Trypanosoma brucei.

  1997cited by this paper
• Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.

  1997cited by this paper
• Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

  1997cited by this paper
• Electrostatic interaction of myristoylated proteins with membranes: simple physics, complicated biology.

  1997cited by this paper
• N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.

  1997cited by this paper
• Human N-Myristoyltransferase Amino-terminal Domain Involved in Targeting the Enzyme to the Ribosomal Subcellular Fraction*

  1997cited by this paper
• Characterisation of a second protein encoded by the differentially regulated LmcDNA16 gene family of Leishmania major.

  1997cited by this paper
• Characterisation of protein isoprenylation in procyclic form Trypanosoma brucei.

  1996cited by this paper
• Comparative protein modeling by satisfaction of spatial restraints.

  1996cited by this paper
• Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.

  1996cited by this paper
• Comparative protein modeling by satisfaction of spatial restraints

  1995cited by this paper
• Genetic studies reveal that myristoylCoA:protein N‐myristoyltransferase is an essential enzyme in Candida albicans

  1995cited by this paper
• The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions.

  1995cited by this paper
• Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

  1995cited by this paper
• Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.

  1994cited by this paper
• Expression of a hydrophilic surface protein in infective stages of Leishmania major.

  1994cited by this paper
• Genetic and biochemical studies of protein N-myristoylation.

  1994cited by this paper
• Toxicity of myristic acid analogs toward African trypanosomes.

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Protein prenyltransferases.

  1992cited by this paper
• Biochemistry of protein prenylation.

  1992cited by this paper
• Geranylgeranylated proteins : Molecular and immunological approaches to the study of synaptic and axonal glycoproteins

  1992cited by this paper
• Geranylgeranylated proteins.

  1992cited by this paper
• Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase.

  1991cited by this paper
• An analog of myristic acid with selective toxicity for African trypanosomes.

  1991cited by this paper
• Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.

  1990cited by this paper
• A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane.

  1990cited by this paper
• Brain G protein gamma subunits contain an all-trans-geranylgeranylcysteine methyl ester at their carboxyl termini.

  1990cited by this paper
• Prenyl proteins in eukaryotic cells: a new type of membrane anchor.

  1990cited by this paper
• Purification and characterization from bovine brain cytosol of a protein that inhibits the dissociation of GDP from and the subsequent binding of GTP to smg p25A, a ras p21-like GTP-binding protein.

  1990influential reference
• Disruption of the yeast N-myristoyl transferase gene causes recessive lethality.

  1989cited by this paper

• Virtual screening of flavonoids as potential inhibitors of Candida species: An in silico approach utilizing ADMET and molecular docking studies

  2025cites this paper
• Exploring Subsite Selectivity within Plasmodium vivaxN-Myristoyltransferase Using Pyrazole-Derived Inhibitors

  2024cites this paper
• Overview of the Properties of Glutamic Peptidases That Are Present in Plant and Bacterial Pathogens and Play a Role in Celiac Disease and Cancer.

  2023cites this paper
• Antimalarial activities of benzothiazole analogs: A systematic review

  2023cites this paper
• Appraising Onchocerciasis Community Directed Treatment with Ivermectin: Problems, Progress and Prospects

  2023cites this paper
• Re-screening and preliminary in vitro evaluation of resorcinol based Hsp90 inhibitors for potential protocidal activity

  2023cites this paper
• Molecular structural investigations of quinoxaline derivatives through 3D-QSAR, molecular docking, ADME prediction and pharmacophore modeling studies for the search of novel antimalarial agent

  2022cites this paper
• Computational approaches for drug discovery against trypanosomatid-caused diseases

  2020cites this paper
• HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics

  2020cites this paper
• Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease

  2019cites this paper
• Contributions of bioinformatics to study natural antifungals: review in a pharmacological context

  2019cites this paper
• Computational and Metabolic Studies on a Set of N-Myristoyltransferase Inhibitors Against Trypanosoma Brucei

  2018cites this paper
• Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease

  2018cites this paper
• A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors

  2018cites this paper
• Antibiofilm activity and molecular docking studies of bioactive secondary metabolites from endophytic fungus Aspergillus nidulans on oral Candida albicans

  2018cites this paper
• Rce1: mechanism and inhibition

  2018cites this paper
• Novel Therapeutic Approaches for Trypanosoma cruzi Infection

  2018cites this paper
• A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets.

  2017cites this paper
• Targeting Trypanosoma brucei FPPs by fragment- based drug discovery

  2017cites this paper
• Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones

  2016cites this paper
• Global proteomic analysis of prenylated proteins in Plasmodium falciparum using an alkyne-modified isoprenoid analogue

  2016cites this paper
• N‐Myristoyltransferase as a Target for Drug Discovery in Malaria

  2016cites this paper
• Repurposing strategies for tropical disease drug discovery.

  2016cites this paper
• Carbon Metabolism of Plasmodium falciparum

  2016cites this paper
• Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015)

  2016cites this paper
• Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis

  2016cites this paper
• Erratum: Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis

  2016cites this paper
• 4-aminoquinolines: An Overview of Antimalarial Chemotherapy

  2016cites this paper
• MOLECULAR DOCKING STUDY OF NATURALLYOCCURRING COMPOUNDS AS INHIBITORS OF N-MYRISTOYL TRANSFERASE TOWARDS ANTIFUNGAL AGENTS DISCOVERY

  2015cites this paper
• New horizons in antimalarial drug discovery in the last decade by chemoinformatic approaches.

  2015cites this paper
• ALVOS MOLECULARES PROMISSORES PARA O DESENVOLVIMENTO DE NOVOS FÁRMACOS ANTICHAGÁSICOS

  2015cites this paper
• Acylation in trypanosomatids: an essential process and potential drug target.

  2014cites this paper
• Characterization of N-Myristoyltransferases in Vertebrate Embryos by Using Zebrafish: Appearance of Low Molecular Weight N-Myristoyltransferase 1 in Early Development

  2014cites this paper
• Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites

  2014cites this paper
• Recent Advances in The Discovery of N‐Myristoyltransferase Inhibitors

  2014cites this paper
• Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-myristoylation in Intracellular Leishmania Amastigotes

  2014cites this paper
• A Target Repurposing Approach Identifies N-myristoyltransferase as a New Candidate Drug Target in Filarial Nematodes

  2014cites this paper
• Regulation of N-myristoyltransferase by the calpain and caspase systems.

  2014cites this paper
• Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design

  2014cites this paper
• New Chemical Scaffolds for Human African Trypanosomiasis Lead Discovery from a Screen of Tyrosine Kinase Inhibitor Drugs

  2014cites this paper
• N-Myristoyltransferase inhibition as a tool for antileishmanial drug discovery: Use in high- throughput, de novo, and piggyback strategies for drug development

  2014cites this paper
• Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins

  2013cites this paper
• N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis

  2013cites this paper
• Validation of N-myristoyltransferase as potential chemotherapeutic target in Chagas disease

  2013cites this paper
• Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

  2013cites this paper
• Photoactive analogs of farnesyl diphosphate and related isoprenoids: design and applications in studies of medicinally important isoprenoid-utilizing enzymes.

  2013cites this paper
• Correction: Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign

  2013cites this paper
• Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs

  2012cites this paper
• Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.

  2012cites this paper
• Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents.

  2012cites this paper
• Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51

  2012cites this paper
• New Antiplasmodial Bromotyrosine Derivatives from Suberea ianthelliformis Lendenfeld, 1888

  2012cites this paper
• 2D Chemometrics analyses of tetrahydroquinoline and ethylenediamine derivatives with antimalarial activity.

  2012cites this paper
• Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign

  2012cites this paper
• Photochemical Modulation of Ras‐Mediated Signal Transduction Using Caged Farnesyltransferase Inhibitors: Activation by One‐ and Two‐Photon Excitation

  2012cites this paper
• Structural insight for imidazopyridazines as malarial kinase PfPK7 inhibitors using QSAR techniques.

  2012cites this paper
• New antibacterials for the treatment of toxoplasmosis; a patent review

  2012cites this paper
• Molecular Recognition of Substrates by Protein Farnesyltransferase and Geranylgeranyltransferase-I.

  2012cites this paper
• Global Identification of Protein Prenyltransferase Substrates: Defining the Prenylated Proteome

  2011cites this paper
• N-myristoyltransferase in the leukocytic development processes

  2011cites this paper
• Non-Bisphosphonate Inhibitors of Isoprenoid Biosynthesis Identified via Computer-Aided Drug Design

  2011cites this paper
• A decade of targets and patented drugs for chemotherapy of Chagas disease.

  2011cites this paper
• An Essential Farnesylated Kinesin in Trypanosoma brucei

  2011cites this paper
• CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents

  2011cites this paper
• Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

  2011cites this paper
• Selective Inhibitors of Methionyl-tRNA Synthetase Have Potent Activity against Trypanosoma brucei Infection in Mice

  2011cites this paper
• Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.

  2011cites this paper
• Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection.

  2011cites this paper
• The Ras Converting Enzyme (Rce1p)

  2011cites this paper
• Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors

  2011cites this paper
• Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens*

  2011cites this paper
• Chapter 10 - The Ras Converting Enzyme (Rce1p): Orthologs, Enzymology, and Inhibitors

  2011cites this paper
• Mechanistic Studies of Protein Lipidation: Yeast Palmitoyltransferase Akr1p and Protein Farnesyltransferase.

  2011cites this paper
• Structural Biochemistry of CaaX Protein Prenyltransferases

  2011cites this paper
• Structure-activity relationships of mononuclear metal-thiosemicarbazone complexes endowed with potent antiplasmodial and antiamoebic activities.

  2010cites this paper
• Structural Biochemistry and Inhibition of CaaX Protein Prenyltransferases From Human Pathogens

  2010cites this paper
• Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

  2010cites this paper
• dentification of inhibitors for putative malaria drug targets among novel ntimalarial compounds regory

  2010cites this paper
• Trioxaquines: hybrid molecules for the treatment of malaria.

  2010cites this paper
• Lipid metabolism in Trypanosoma brucei.

  2010cites this paper
• N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis

  2010cites this paper
• Biochemistry of Trypanosoma cruzi

  2010cites this paper
• Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development

  2009cites this paper
• A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni

  2009cites this paper
• Comparative Expression Profiling of Leishmania: Modulation in Gene Expression between Species and in Different Host Genetic Backgrounds

  2009cites this paper
• Myristoyl CoA:protein N-myristoyl transferase : a target for a novel antimalarial drug

  2009cites this paper
• Three-dimensional quantitative structure–farnesyltransferase inhibition analysis for some diaminobenzophenones

  2009cites this paper
• Myristoylated adenylate kinase-2 of Plasmodium falciparum forms a heterodimer with myristoyltransferase.

  2009cites this paper
• Context-dependent substrate recognition by protein farnesyltransferase.

  2009cites this paper
• Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure–activity relationships and molecular docking

  2009cites this paper
• Structure-based drug discovery for tropical diseases.

  2009cites this paper
• Approaches for the development of new anti-Trypanosoma cruzi agents.

  2009cites this paper
• Protozoan protein tyrosine phosphatases.

  2008cites this paper
• Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

  2008cites this paper
• Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.

  2008cites this paper
• QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.

  2008cites this paper
• Novel Molecular Targets for Antimalarial Drug Development

  2008cites this paper
• Characterization of a PRL protein tyrosine phosphatase from Plasmodium falciparum.

  2008cites this paper
• Discovery of new targets for antimalarial chemotherapy.

  2008cites this paper
• N‐Myristoyltransferase: a Prospective Drug Target for Protozoan Parasites

  2008cites this paper